Cargando…

Analysis of Patients with Helicobacter pylori Infection and the Subsequent Risk of Developing Osteoporosis after Eradication Therapy: A Nationwide Population-Based Cohort Study

PURPOSE: Previous studies have reported conflicting results on the association between Helicobacter pylori infection and osteoporosis. A few studies have discussed the influence of H. pylori eradication therapy on bone mineral density. METHODS: We assessed the prevalence of osteoporosis among the H....

Descripción completa

Detalles Bibliográficos
Autores principales: Shih, Hong-Mo, Hsu, Tai-Yi, Chen, Chih-Yu, Lin, Cheng-Li, Kao, Chia-Hung, Chen, Chao-Hsien, Yang, Tse-Yen, Chen, Wei-Kung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023099/
https://www.ncbi.nlm.nih.gov/pubmed/27626940
http://dx.doi.org/10.1371/journal.pone.0162645
_version_ 1782453617367711744
author Shih, Hong-Mo
Hsu, Tai-Yi
Chen, Chih-Yu
Lin, Cheng-Li
Kao, Chia-Hung
Chen, Chao-Hsien
Yang, Tse-Yen
Chen, Wei-Kung
author_facet Shih, Hong-Mo
Hsu, Tai-Yi
Chen, Chih-Yu
Lin, Cheng-Li
Kao, Chia-Hung
Chen, Chao-Hsien
Yang, Tse-Yen
Chen, Wei-Kung
author_sort Shih, Hong-Mo
collection PubMed
description PURPOSE: Previous studies have reported conflicting results on the association between Helicobacter pylori infection and osteoporosis. A few studies have discussed the influence of H. pylori eradication therapy on bone mineral density. METHODS: We assessed the prevalence of osteoporosis among the H. pylori-infected population in Taiwan and the influence of early and late H. pylori eradication therapy on bone mineral density. RESULTS: Using data from Taiwan's National Health Insurance Research Database, we identified 5,447 patients who received H. pylori eradication therapy from 2000 to 2010 and 21,788 controls, frequency-matched according to age, sex, and year of receiving H. pylori eradication therapy. Those who received H. pylori eradication therapy were divided into two groups based on the time interval between the diagnosis of a peptic ulcer and commencement of eradication therapy. The risk of developing osteoporosis was higher in the early H. pylori treatment cohort (hazard ratio [HR] = 1.52, 95% confidence interval [CI] = 1.23–1.89) and late H. pylori treatment cohort (HR = 1.69, 95% CI = 1.39–2.05), compared with the risk in the control cohort. When followed for less than 5 years, both the early and late cohorts had a higher risk of developing osteoporosis (HR = 1.69, 95% CI = 1.32–2.16 and HR = 1.72, 95% CI = 1.38–2.14). However, when the follow-up period was over 5 years, only the late eradication group exhibited a higher incidence of osteoporosis (HR = 1.62, 95% CI = 1.06–2.47). CONCLUSION: The development of osteoporosis is complex and multi-factorial. Via this population-based cohort study and adjustment of possible confounding variables, we found H. pylori infection may be associated with an increased risk of developing osteoporosis in Taiwan. Early eradication could reduce the influence of H. pylori infection on osteoporosis when the follow-up period is greater than 5 years. Further prospective studies are necessary to discover the connection of H. pylori and osteoporosis.
format Online
Article
Text
id pubmed-5023099
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-50230992016-09-27 Analysis of Patients with Helicobacter pylori Infection and the Subsequent Risk of Developing Osteoporosis after Eradication Therapy: A Nationwide Population-Based Cohort Study Shih, Hong-Mo Hsu, Tai-Yi Chen, Chih-Yu Lin, Cheng-Li Kao, Chia-Hung Chen, Chao-Hsien Yang, Tse-Yen Chen, Wei-Kung PLoS One Research Article PURPOSE: Previous studies have reported conflicting results on the association between Helicobacter pylori infection and osteoporosis. A few studies have discussed the influence of H. pylori eradication therapy on bone mineral density. METHODS: We assessed the prevalence of osteoporosis among the H. pylori-infected population in Taiwan and the influence of early and late H. pylori eradication therapy on bone mineral density. RESULTS: Using data from Taiwan's National Health Insurance Research Database, we identified 5,447 patients who received H. pylori eradication therapy from 2000 to 2010 and 21,788 controls, frequency-matched according to age, sex, and year of receiving H. pylori eradication therapy. Those who received H. pylori eradication therapy were divided into two groups based on the time interval between the diagnosis of a peptic ulcer and commencement of eradication therapy. The risk of developing osteoporosis was higher in the early H. pylori treatment cohort (hazard ratio [HR] = 1.52, 95% confidence interval [CI] = 1.23–1.89) and late H. pylori treatment cohort (HR = 1.69, 95% CI = 1.39–2.05), compared with the risk in the control cohort. When followed for less than 5 years, both the early and late cohorts had a higher risk of developing osteoporosis (HR = 1.69, 95% CI = 1.32–2.16 and HR = 1.72, 95% CI = 1.38–2.14). However, when the follow-up period was over 5 years, only the late eradication group exhibited a higher incidence of osteoporosis (HR = 1.62, 95% CI = 1.06–2.47). CONCLUSION: The development of osteoporosis is complex and multi-factorial. Via this population-based cohort study and adjustment of possible confounding variables, we found H. pylori infection may be associated with an increased risk of developing osteoporosis in Taiwan. Early eradication could reduce the influence of H. pylori infection on osteoporosis when the follow-up period is greater than 5 years. Further prospective studies are necessary to discover the connection of H. pylori and osteoporosis. Public Library of Science 2016-09-14 /pmc/articles/PMC5023099/ /pubmed/27626940 http://dx.doi.org/10.1371/journal.pone.0162645 Text en © 2016 Shih et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Shih, Hong-Mo
Hsu, Tai-Yi
Chen, Chih-Yu
Lin, Cheng-Li
Kao, Chia-Hung
Chen, Chao-Hsien
Yang, Tse-Yen
Chen, Wei-Kung
Analysis of Patients with Helicobacter pylori Infection and the Subsequent Risk of Developing Osteoporosis after Eradication Therapy: A Nationwide Population-Based Cohort Study
title Analysis of Patients with Helicobacter pylori Infection and the Subsequent Risk of Developing Osteoporosis after Eradication Therapy: A Nationwide Population-Based Cohort Study
title_full Analysis of Patients with Helicobacter pylori Infection and the Subsequent Risk of Developing Osteoporosis after Eradication Therapy: A Nationwide Population-Based Cohort Study
title_fullStr Analysis of Patients with Helicobacter pylori Infection and the Subsequent Risk of Developing Osteoporosis after Eradication Therapy: A Nationwide Population-Based Cohort Study
title_full_unstemmed Analysis of Patients with Helicobacter pylori Infection and the Subsequent Risk of Developing Osteoporosis after Eradication Therapy: A Nationwide Population-Based Cohort Study
title_short Analysis of Patients with Helicobacter pylori Infection and the Subsequent Risk of Developing Osteoporosis after Eradication Therapy: A Nationwide Population-Based Cohort Study
title_sort analysis of patients with helicobacter pylori infection and the subsequent risk of developing osteoporosis after eradication therapy: a nationwide population-based cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023099/
https://www.ncbi.nlm.nih.gov/pubmed/27626940
http://dx.doi.org/10.1371/journal.pone.0162645
work_keys_str_mv AT shihhongmo analysisofpatientswithhelicobacterpyloriinfectionandthesubsequentriskofdevelopingosteoporosisaftereradicationtherapyanationwidepopulationbasedcohortstudy
AT hsutaiyi analysisofpatientswithhelicobacterpyloriinfectionandthesubsequentriskofdevelopingosteoporosisaftereradicationtherapyanationwidepopulationbasedcohortstudy
AT chenchihyu analysisofpatientswithhelicobacterpyloriinfectionandthesubsequentriskofdevelopingosteoporosisaftereradicationtherapyanationwidepopulationbasedcohortstudy
AT linchengli analysisofpatientswithhelicobacterpyloriinfectionandthesubsequentriskofdevelopingosteoporosisaftereradicationtherapyanationwidepopulationbasedcohortstudy
AT kaochiahung analysisofpatientswithhelicobacterpyloriinfectionandthesubsequentriskofdevelopingosteoporosisaftereradicationtherapyanationwidepopulationbasedcohortstudy
AT chenchaohsien analysisofpatientswithhelicobacterpyloriinfectionandthesubsequentriskofdevelopingosteoporosisaftereradicationtherapyanationwidepopulationbasedcohortstudy
AT yangtseyen analysisofpatientswithhelicobacterpyloriinfectionandthesubsequentriskofdevelopingosteoporosisaftereradicationtherapyanationwidepopulationbasedcohortstudy
AT chenweikung analysisofpatientswithhelicobacterpyloriinfectionandthesubsequentriskofdevelopingosteoporosisaftereradicationtherapyanationwidepopulationbasedcohortstudy